The invention relates to a separation and purification method of a pneumocandin B0
serine analog. The separation and purification method comprises the following steps of (a) performing chromatographyenrichment for the first time through
polymer substrate chromatogram fillings, performing
isocratic elution, and collecting parts of which the purity is greater than 30%; (b) performing chromatographyenrichment for the second time through chromatogram fillings having hydrophilic effects, performing
isocratic elution, and collecting parts of which the purity is greater than 60%; (c) performing
chromatography enrichment for the third time through antiphase
silica gel substrate chromatogram fillings, performing
isocratic elution, and collecting parts of which the purity is greater than 80%; and(d) after purifying for the third time, performing decompressed concentration on
chromatography liquid of which the pneumocandin B0
serine analog purity is greater than 80%, removing a
solvent, and performing freeze-
drying so as to obtain the pneumocandin B0
serine analog. Through the adoption of the preparation method disclosed by the invention, the pneumocandin B0 serine analog of which the purity is greater than 80% is subjected to structure identification, and a base is established for further performing
biological activity screening or performing
biological activity screening after
structure modification.